Chemed (FRA:CXM) Total Receivables: €186 Mil (As of Mar. 2026)


FRA:CXM Chemed Corp FRA:CXM
76 GF Score
Price €400.00
GF Value €567.34
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Chemed Total Receivables?

Chemed FRA:CXM -0.99% 76 Total Receivables is €186 Mil as of Mar. 2026. GuruFocus rates FRA:CXM with a GF Score™ of 76/100 and a GF Value™ of €567.34 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Chemed's Total Receivables for the quarter that ended in Mar. 2026 was €186 Mil.

Chemed Total Receivables Historical Data

* Premium members only.

The historical data trend for Chemed's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemed Total Receivables Chart

Chemed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 121.44 131.60 166.45 163.46 155.92

Chemed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 264.43 160.29 183.67 155.92 186.39
FRA:CXM
76GF Score
Chemed Corp FRA:CXM
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemed Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €186 Mil mean?
Chemed (FRA:CXM) has a Total Receivables of €186 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Chemed and its competitors.
Is Chemed's Total Receivables too high?
Chemed's current Total Receivables is €186 Mil. Overall, Chemed has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chemed's Total Receivables compare to PACS and LFST?
Chemed's Total Receivables of €186 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Healthcare Providers & Services company?
A good Total Receivables depends on the Healthcare Providers & Services industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Chemed and its competitors. Chemed's current Total Receivables is €186 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemed stock overvalued right now?
Based on GuruFocus' analysis, Chemed (FRA:CXM) is currently considered Modestly Undervalued. The stock's GF Value™ is €567.34, compared to a current price of €400.00 — trading 29.5% below its estimated fair value. The current Total Receivables is €186 Mil. Chemed's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Chemed (FRA:CXM), the current Total Receivables is €186 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemed (FRA:CXM) Overvalued in 2026?

Based on GuruFocus' analysis, Chemed stock appears to be undervalued. The current stock price of €400.00 is trading 29.5% below its estimated GF Value™ of €567.34. GuruFocus considers Chemed to be Modestly Undervalued.

Key valuation signals for FRA:CXM:

  • Total Receivables: €186 Mil
  • GF Value™: €567.34 vs. price of €400.00 (29.5% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the FRA:CXM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chemed Business Description

Other Exchanges CHE:USA
Address 255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
76GF Score

Get the complete analysis for FRA:CXM

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€400.00
Price
€567.34
GF Value